Could a diabetes drug beat a standard melasma treatment?
NCT ID NCT07485777
First seen Apr 07, 2026 · Last updated May 08, 2026 · Updated 2 times
Summary
This study tests whether a cream made from 30% metformin (a diabetes drug) works better and causes fewer side effects than the standard Kligman's regimen for treating melasma, a skin condition causing dark patches on the face. About 82 women aged 35-55 will use one of the two creams plus sunscreen for 8 weeks. Researchers will measure changes in skin pigmentation and track any irritation or burning.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MELASMA (FACIAL MELASMA) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fauji Foundation Hospital, Rawalpindi
Rawalpindi, Punjab Province, 44000, Pakistan
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.